FDA 483 - Pharmalab 1982 Inc. Dba. Ideal Protein - June 03, 2022

An FDA inspection of Pharmalab 1982 Inc. Dba. Ideal Protein, a dietary supplement manufacturer, identified two significant issues. The firm failed to ensure packaging and labels conformed to master manufacturing records, specifically by not listing fish and soy ingredients on a Multi-Vita Mineral Supplement label. Additionally, the company did not use appropriate, scientifically valid methods for finished product testing, instead relying on 'supervised addition' or 'production input' for ingredient verification.